New Approaches to Bone Marrow Transplantation

VIDEO | 06:00

Sergio Giralt, Chief of the Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center, says that patients with bone marrow that is free of abnormal white blood cells may be candidates for autologous transplantation. This therapy is the most common transplant procedure for patients with myeloma. For patients who undergo allogeneic transplants, doctors at Memorial Sloan Kettering have pioneered a technique for preventing graft-versus-host disease, an acute immune complication that can sometime occur after the transplant. Despite the risk of graft-versus-host disease, people with certain types of leukemia may benefit from the immune response  generated by an allogeneic transplant to prevent the cancer from returning.